XPO1 inhibitor KPT-330 synergizes with Bcl-xL inhibitor to induce cancer cell apoptosis by perturbing rRNA processing and Mcl-1 protein synthesis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-4889
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
XPO1 inhibitor KPT-330 synergizes with Bcl-xL inhibitor to induce cancer cell apoptosis by perturbing rRNA processing and Mcl-1 protein synthesis ; volume:10 ; number:6 ; day:21 ; month:5 ; year:2019 ; pages:1-14 ; date:6.2019
Cell death & disease ; 10, Heft 6 (21.5.2019), 1-14, 6.2019
- Urheber
-
Zhu, Zhi-Chuan
Liu, Ji-Wei
Yang, Can
Zhao, Miao
Xiong, Zhi-Qi
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41419-019-1627-9
- URN
-
urn:nbn:de:101:1-2019102209495592592046
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:28 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zhu, Zhi-Chuan
- Liu, Ji-Wei
- Yang, Can
- Zhao, Miao
- Xiong, Zhi-Qi
- SpringerLink (Online service)
Ähnliche Objekte (12)
A novel Mcl-1 inhibitor synergizes with venetoclax to induce apoptosis in cancer cells
Synthesis of a Macrocyclic Mcl-1 Inhibitor
Class I HDAC inhibitor entinostat synergizes with PLK1 inhibitors in MYC-amplified medulloblastoma cells
BCL-XL inhibitors enhance the apoptotic efficacy of BRAF inhibitors in BRAF V600E colorectal cancer
Targeting antiapoptotic proteins Bcl-xL and Mcl-1 in cholangiocarcinoma
Discovery of a small-molecule inhibitor that traps Polθ on DNA and synergizes with PARP inhibitors
Der Apoptosis-Inhibitor Bcl-xl in neuronalem Zelltod und der Alzheimer-Krankheit
Discovery of a PFKFB3 inhibitor for phase I trial testing that synergizes with the B-Raf inhibitor vemurafenib
BCL-XL PROTAC degrader DT2216 synergizes with sotorasib in preclinical models of KRASG12C-mutated cancers
Topotecan synergizes with CHEK1 (CHK1) inhibitor to induce apoptosis in ovarian cancer cells
Preclinical studies of Apogossypolone: a new nonpeptidic pan small-molecule inhibitor of Bcl-2, Bcl-XL and Mcl-1 proteins in Follicular Small Cleaved Cell Lymphoma model
Small‐Molecule and Peptide Inhibitors of the Pro‐Survival Protein Mcl‐1
A novel Mcl-1 inhibitor synergizes with venetoclax to induce apoptosis in cancer cells
Synthesis of a Macrocyclic Mcl-1 Inhibitor
Class I HDAC inhibitor entinostat synergizes with PLK1 inhibitors in MYC-amplified medulloblastoma cells
BCL-XL inhibitors enhance the apoptotic efficacy of BRAF inhibitors in BRAF V600E colorectal cancer
Targeting antiapoptotic proteins Bcl-xL and Mcl-1 in cholangiocarcinoma
Discovery of a small-molecule inhibitor that traps Polθ on DNA and synergizes with PARP inhibitors
Der Apoptosis-Inhibitor Bcl-xl in neuronalem Zelltod und der Alzheimer-Krankheit
Discovery of a PFKFB3 inhibitor for phase I trial testing that synergizes with the B-Raf inhibitor vemurafenib
BCL-XL PROTAC degrader DT2216 synergizes with sotorasib in preclinical models of KRASG12C-mutated cancers
Topotecan synergizes with CHEK1 (CHK1) inhibitor to induce apoptosis in ovarian cancer cells
Preclinical studies of Apogossypolone: a new nonpeptidic pan small-molecule inhibitor of Bcl-2, Bcl-XL and Mcl-1 proteins in Follicular Small Cleaved Cell Lymphoma model
Small‐Molecule and Peptide Inhibitors of the Pro‐Survival Protein Mcl‐1
A novel Mcl-1 inhibitor synergizes with venetoclax to induce apoptosis in cancer cells
Synthesis of a Macrocyclic Mcl-1 Inhibitor
Class I HDAC inhibitor entinostat synergizes with PLK1 inhibitors in MYC-amplified medulloblastoma cells
BCL-XL inhibitors enhance the apoptotic efficacy of BRAF inhibitors in BRAF V600E colorectal cancer
Targeting antiapoptotic proteins Bcl-xL and Mcl-1 in cholangiocarcinoma
Discovery of a small-molecule inhibitor that traps Polθ on DNA and synergizes with PARP inhibitors
Der Apoptosis-Inhibitor Bcl-xl in neuronalem Zelltod und der Alzheimer-Krankheit
Discovery of a PFKFB3 inhibitor for phase I trial testing that synergizes with the B-Raf inhibitor vemurafenib
BCL-XL PROTAC degrader DT2216 synergizes with sotorasib in preclinical models of KRASG12C-mutated cancers
Topotecan synergizes with CHEK1 (CHK1) inhibitor to induce apoptosis in ovarian cancer cells
Preclinical studies of Apogossypolone: a new nonpeptidic pan small-molecule inhibitor of Bcl-2, Bcl-XL and Mcl-1 proteins in Follicular Small Cleaved Cell Lymphoma model